Tobin James R sold 59 shares of TransMedics Group, Inc. at $93.96 for −$5.54k on Nov 9, 2026

Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
Director
DIR
Filed Nov 12, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
−$5,543.64Shares × reported price
Shares traded
59Common Stock
Price per share
$93.96Reported price. Read footnotes for ranges.
% of reported position traded
0.85%This security and ownership context
Holdings after
6,922Direct
Trade date
Nov 9, 2026Sell
Filed
Nov 12, 2026, 4:15 PM ET3-day reporting delay
Accession
0001193125-26-458437Code S · Transaction 398863
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 6,981 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Nov 9, 2026Sell4,000$94.98−$379,920Trade 398864
2 transaction rows in this filing. Joint filers share the same rows.

TMDX price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
TMDX · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Nov 19, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago −15%1w ago −28%1d ago −4.1%
Returns since7d30d90d180d1y

Footnotes in full

F1: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $94.98 to $95.01, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.